Axonics' implantable sacral neurostimulator gets European CE mark

May 18, 2021 9:08 AM ETAxonics, Inc. (AXNX)By: Mamta Mayani, SA News Editor

Axonics (NASDAQ:AXNX) announces European CE Mark approval of its second generation Axonics r-SNM implantable neurostimulator (INS) and wireless patient remote control with SmartMRI technology.
Axonics previously received FDA approval for this INS and remote control during 2020. This version reduces how frequently a patient needs to recharge their sacral neuromodulation device to just once a month for about one hour.
The newly approved remote control simplifies the process by which patients can receive a full-body MRI, avoiding the need to visit physician’s office.